Apcotex Industries Limited (APCOTEXIND.NS) Stock Competitors & Peer Comparison
See (APCOTEXIND.NS) competitors and their performances in Stock Market.
Peer Comparison Table: Chemicals - Specialty Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| APCOTEXIND.NS | ₹534.85 | +3.50% | 27.9B | 27.56 | ₹19.56 | +1.30% |
| ASIANPAINT.NS | ₹2,715.10 | +2.10% | 2.6T | 59.99 | ₹45.14 | +0.93% |
| ASIANPAINT.BO | ₹2,714.85 | +2.09% | 2.6T | 67.31 | ₹40.22 | +0.93% |
| SOLARINDS.BO | ₹17,655.00 | -2.67% | 1.7T | 98.65 | ₹185.03 | +0.05% |
| SOLARINDS.NS | ₹17,697.00 | -2.30% | 1.7T | 98.87 | ₹184.76 | +0.05% |
| PIDILITIND.BO | ₹1,503.95 | +3.08% | 1.5T | 65.92 | ₹22.48 | +1.01% |
| PIDILITIND.NS | ₹1,506.50 | +3.20% | 1.5T | 61.90 | ₹23.94 | +1.01% |
| SRF.NS | ₹2,734.10 | +2.23% | 797.3B | 43.42 | ₹61.94 | +0.33% |
| SRF.BO | ₹2,737.00 | +2.33% | 796.1B | 43.47 | ₹61.79 | +0.33% |
| BERGEPAINT.BO | ₹519.60 | +5.81% | 587B | 54.31 | ₹9.27 | +0.76% |
Stock Comparison
APCOTEXIND.NS vs ASIANPAINT.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, ASIANPAINT.NS has a market cap of 2.6T. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while ASIANPAINT.NS trades at ₹2,715.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas ASIANPAINT.NS's P/E ratio is 59.99. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to ASIANPAINT.NS's ROE of +0.22%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to ASIANPAINT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check ASIANPAINT.NS's competition here
APCOTEXIND.NS vs ASIANPAINT.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, ASIANPAINT.BO has a market cap of 2.6T. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while ASIANPAINT.BO trades at ₹2,714.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas ASIANPAINT.BO's P/E ratio is 67.31. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to ASIANPAINT.BO's ROE of +0.22%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to ASIANPAINT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check ASIANPAINT.BO's competition here
APCOTEXIND.NS vs SOLARINDS.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, SOLARINDS.BO has a market cap of 1.7T. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while SOLARINDS.BO trades at ₹17,655.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas SOLARINDS.BO's P/E ratio is 98.65. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to SOLARINDS.BO's ROE of +0.33%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to SOLARINDS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check SOLARINDS.BO's competition here
APCOTEXIND.NS vs SOLARINDS.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, SOLARINDS.NS has a market cap of 1.7T. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while SOLARINDS.NS trades at ₹17,697.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas SOLARINDS.NS's P/E ratio is 98.87. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to SOLARINDS.NS's ROE of +0.33%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to SOLARINDS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check SOLARINDS.NS's competition here
APCOTEXIND.NS vs PIDILITIND.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, PIDILITIND.BO has a market cap of 1.5T. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while PIDILITIND.BO trades at ₹1,503.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas PIDILITIND.BO's P/E ratio is 65.92. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to PIDILITIND.BO's ROE of +0.24%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to PIDILITIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check PIDILITIND.BO's competition here
APCOTEXIND.NS vs PIDILITIND.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, PIDILITIND.NS has a market cap of 1.5T. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while PIDILITIND.NS trades at ₹1,506.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas PIDILITIND.NS's P/E ratio is 61.90. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to PIDILITIND.NS's ROE of +0.24%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to PIDILITIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check PIDILITIND.NS's competition here
APCOTEXIND.NS vs SRF.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, SRF.NS has a market cap of 797.3B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while SRF.NS trades at ₹2,734.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas SRF.NS's P/E ratio is 43.42. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to SRF.NS's ROE of +0.14%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to SRF.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check SRF.NS's competition here
APCOTEXIND.NS vs SRF.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, SRF.BO has a market cap of 796.1B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while SRF.BO trades at ₹2,737.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas SRF.BO's P/E ratio is 43.47. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to SRF.BO's ROE of +0.14%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to SRF.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check SRF.BO's competition here
APCOTEXIND.NS vs BERGEPAINT.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, BERGEPAINT.BO has a market cap of 587B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while BERGEPAINT.BO trades at ₹519.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas BERGEPAINT.BO's P/E ratio is 54.31. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to BERGEPAINT.BO's ROE of +0.18%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to BERGEPAINT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check BERGEPAINT.BO's competition here
APCOTEXIND.NS vs BERGEPAINT.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, BERGEPAINT.NS has a market cap of 585.2B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while BERGEPAINT.NS trades at ₹516.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas BERGEPAINT.NS's P/E ratio is 51.96. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to BERGEPAINT.NS's ROE of +0.18%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to BERGEPAINT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check BERGEPAINT.NS's competition here
APCOTEXIND.NS vs LINDEINDIA.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, LINDEINDIA.NS has a market cap of 584.6B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while LINDEINDIA.NS trades at ₹6,750.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas LINDEINDIA.NS's P/E ratio is 106.28. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to LINDEINDIA.NS's ROE of +0.14%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to LINDEINDIA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check LINDEINDIA.NS's competition here
APCOTEXIND.NS vs LINDEINDIA.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, LINDEINDIA.BO has a market cap of 583.5B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while LINDEINDIA.BO trades at ₹6,745.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas LINDEINDIA.BO's P/E ratio is 106.12. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to LINDEINDIA.BO's ROE of +0.14%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to LINDEINDIA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check LINDEINDIA.BO's competition here
APCOTEXIND.NS vs FLUOROCHEM.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, FLUOROCHEM.NS has a market cap of 393.1B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while FLUOROCHEM.NS trades at ₹3,641.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas FLUOROCHEM.NS's P/E ratio is 68.31. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to FLUOROCHEM.NS's ROE of +0.08%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to FLUOROCHEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check FLUOROCHEM.NS's competition here
APCOTEXIND.NS vs FLUOROCHEM.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, FLUOROCHEM.BO has a market cap of 393.1B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while FLUOROCHEM.BO trades at ₹3,640.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas FLUOROCHEM.BO's P/E ratio is 67.96. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to FLUOROCHEM.BO's ROE of +0.08%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to FLUOROCHEM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check FLUOROCHEM.BO's competition here
APCOTEXIND.NS vs HSCL.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, HSCL.NS has a market cap of 342.8B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while HSCL.NS trades at ₹693.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas HSCL.NS's P/E ratio is 45.30. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to HSCL.NS's ROE of +0.18%. Regarding short-term risk, APCOTEXIND.NS is less volatile compared to HSCL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check HSCL.NS's competition here
APCOTEXIND.NS vs HSCL.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, HSCL.BO has a market cap of 342.7B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while HSCL.BO trades at ₹693.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas HSCL.BO's P/E ratio is 45.19. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to HSCL.BO's ROE of +0.18%. Regarding short-term risk, APCOTEXIND.NS is less volatile compared to HSCL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check HSCL.BO's competition here
APCOTEXIND.NS vs ACUTAAS.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, ACUTAAS.BO has a market cap of 261.9B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while ACUTAAS.BO trades at ₹3,215.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas ACUTAAS.BO's P/E ratio is 91.13. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to ACUTAAS.BO's ROE of +0.12%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to ACUTAAS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check ACUTAAS.BO's competition here
APCOTEXIND.NS vs ACUTAAS.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, ACUTAAS.NS has a market cap of 261.9B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while ACUTAAS.NS trades at ₹3,207.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas ACUTAAS.NS's P/E ratio is 91.52. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to ACUTAAS.NS's ROE of +0.24%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to ACUTAAS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check ACUTAAS.NS's competition here
APCOTEXIND.NS vs ATUL.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, ATUL.NS has a market cap of 195.9B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while ATUL.NS trades at ₹6,641.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas ATUL.NS's P/E ratio is 28.88. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to ATUL.NS's ROE of +0.12%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to ATUL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check ATUL.NS's competition here
APCOTEXIND.NS vs ATUL.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, ATUL.BO has a market cap of 195.1B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while ATUL.BO trades at ₹6,632.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas ATUL.BO's P/E ratio is 32.83. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to ATUL.BO's ROE of +0.12%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to ATUL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check ATUL.BO's competition here
APCOTEXIND.NS vs KANSAINER.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, KANSAINER.NS has a market cap of 169.6B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while KANSAINER.NS trades at ₹214.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas KANSAINER.NS's P/E ratio is 28.81. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to KANSAINER.NS's ROE of +0.09%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to KANSAINER.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check KANSAINER.NS's competition here
APCOTEXIND.NS vs KANSAINER.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, KANSAINER.BO has a market cap of 169.3B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while KANSAINER.BO trades at ₹214.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas KANSAINER.BO's P/E ratio is 28.92. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to KANSAINER.BO's ROE of +0.09%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to KANSAINER.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check KANSAINER.BO's competition here
APCOTEXIND.NS vs DCMSHRIRAM.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, DCMSHRIRAM.NS has a market cap of 159.9B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while DCMSHRIRAM.NS trades at ₹1,032.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas DCMSHRIRAM.NS's P/E ratio is 18.75. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to DCMSHRIRAM.NS's ROE of +0.12%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to DCMSHRIRAM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check DCMSHRIRAM.NS's competition here
APCOTEXIND.NS vs DCMSHRIRAM.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, DCMSHRIRAM.BO has a market cap of 159.9B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while DCMSHRIRAM.BO trades at ₹1,033.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas DCMSHRIRAM.BO's P/E ratio is 18.71. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to DCMSHRIRAM.BO's ROE of +0.12%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to DCMSHRIRAM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check DCMSHRIRAM.BO's competition here
APCOTEXIND.NS vs AARTIIND.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, AARTIIND.NS has a market cap of 159.7B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while AARTIIND.NS trades at ₹433.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas AARTIIND.NS's P/E ratio is 38.16. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to AARTIIND.NS's ROE of +0.07%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to AARTIIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check AARTIIND.NS's competition here
APCOTEXIND.NS vs AARTIIND.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, AARTIIND.BO has a market cap of 159.7B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while AARTIIND.BO trades at ₹432.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas AARTIIND.BO's P/E ratio is 42.30. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to AARTIIND.BO's ROE of +0.07%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to AARTIIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check AARTIIND.BO's competition here
APCOTEXIND.NS vs AETHER.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, AETHER.NS has a market cap of 150.6B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while AETHER.NS trades at ₹1,124.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas AETHER.NS's P/E ratio is 68.87. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to AETHER.NS's ROE of +0.10%. Regarding short-term risk, APCOTEXIND.NS is less volatile compared to AETHER.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check AETHER.NS's competition here
APCOTEXIND.NS vs AETHER.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, AETHER.BO has a market cap of 150.5B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while AETHER.BO trades at ₹1,124.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas AETHER.BO's P/E ratio is 68.52. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to AETHER.BO's ROE of +0.10%. Regarding short-term risk, APCOTEXIND.NS is less volatile compared to AETHER.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check AETHER.BO's competition here
APCOTEXIND.NS vs BASF.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, BASF.NS has a market cap of 145.4B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while BASF.NS trades at ₹3,286.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas BASF.NS's P/E ratio is 34.97. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to BASF.NS's ROE of +0.11%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to BASF.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check BASF.NS's competition here
APCOTEXIND.NS vs FINEORG.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, FINEORG.NS has a market cap of 145.2B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while FINEORG.NS trades at ₹4,716.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas FINEORG.NS's P/E ratio is 34.81. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to FINEORG.NS's ROE of +0.17%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to FINEORG.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check FINEORG.NS's competition here
APCOTEXIND.NS vs FINEORG.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, FINEORG.BO has a market cap of 145.1B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while FINEORG.BO trades at ₹4,700.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas FINEORG.BO's P/E ratio is 34.84. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to FINEORG.BO's ROE of +0.17%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to FINEORG.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check FINEORG.BO's competition here
APCOTEXIND.NS vs BASF.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, BASF.BO has a market cap of 144.9B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while BASF.BO trades at ₹3,292.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas BASF.BO's P/E ratio is 38.66. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to BASF.BO's ROE of +0.11%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to BASF.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check BASF.BO's competition here
APCOTEXIND.NS vs GRWRHITECH.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, GRWRHITECH.BO has a market cap of 144.7B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while GRWRHITECH.BO trades at ₹6,171.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas GRWRHITECH.BO's P/E ratio is 42.69. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to GRWRHITECH.BO's ROE of +0.14%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to GRWRHITECH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check GRWRHITECH.BO's competition here
APCOTEXIND.NS vs GRWRHITECH.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, GRWRHITECH.NS has a market cap of 144.6B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while GRWRHITECH.NS trades at ₹6,208.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas GRWRHITECH.NS's P/E ratio is 42.77. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to GRWRHITECH.NS's ROE of +0.14%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to GRWRHITECH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check GRWRHITECH.NS's competition here
APCOTEXIND.NS vs ANURAS.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, ANURAS.NS has a market cap of 144.3B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while ANURAS.NS trades at ₹1,272.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas ANURAS.NS's P/E ratio is 82.50. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to ANURAS.NS's ROE of +0.05%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to ANURAS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check ANURAS.NS's competition here
APCOTEXIND.NS vs ANURAS.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, ANURAS.BO has a market cap of 144.3B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while ANURAS.BO trades at ₹1,265.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas ANURAS.BO's P/E ratio is 82.35. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to ANURAS.BO's ROE of +0.05%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to ANURAS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check ANURAS.BO's competition here
APCOTEXIND.NS vs AKZOINDIA.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, AKZOINDIA.NS has a market cap of 136B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while AKZOINDIA.NS trades at ₹2,986.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas AKZOINDIA.NS's P/E ratio is 6.95. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to AKZOINDIA.NS's ROE of +1.07%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to AKZOINDIA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check AKZOINDIA.NS's competition here
APCOTEXIND.NS vs AKZOINDIA.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, AKZOINDIA.BO has a market cap of 136B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while AKZOINDIA.BO trades at ₹2,985.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas AKZOINDIA.BO's P/E ratio is 6.95. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to AKZOINDIA.BO's ROE of +1.07%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to AKZOINDIA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check AKZOINDIA.BO's competition here
APCOTEXIND.NS vs VINATIORGA.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, VINATIORGA.NS has a market cap of 134.9B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while VINATIORGA.NS trades at ₹1,309.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas VINATIORGA.NS's P/E ratio is 30.43. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to VINATIORGA.NS's ROE of +0.15%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to VINATIORGA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check VINATIORGA.NS's competition here
APCOTEXIND.NS vs VINATIORGA.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, VINATIORGA.BO has a market cap of 134.8B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while VINATIORGA.BO trades at ₹1,311.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas VINATIORGA.BO's P/E ratio is 30.40. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to VINATIORGA.BO's ROE of +0.15%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to VINATIORGA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check VINATIORGA.BO's competition here
APCOTEXIND.NS vs PRIVISCL.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, PRIVISCL.BO has a market cap of 124.1B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while PRIVISCL.BO trades at ₹3,148.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas PRIVISCL.BO's P/E ratio is 37.80. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to PRIVISCL.BO's ROE of +0.27%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to PRIVISCL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check PRIVISCL.BO's competition here
APCOTEXIND.NS vs PRIVISCL.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, PRIVISCL.NS has a market cap of 124B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while PRIVISCL.NS trades at ₹3,131.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas PRIVISCL.NS's P/E ratio is 37.82. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to PRIVISCL.NS's ROE of +0.27%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to PRIVISCL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check PRIVISCL.NS's competition here
APCOTEXIND.NS vs PCBL.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, PCBL.NS has a market cap of 111.7B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while PCBL.NS trades at ₹287.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas PCBL.NS's P/E ratio is 55.45. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to PCBL.NS's ROE of +0.05%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to PCBL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check PCBL.NS's competition here
APCOTEXIND.NS vs PCBL.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, PCBL.BO has a market cap of 111.6B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while PCBL.BO trades at ₹286.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas PCBL.BO's P/E ratio is 55.27. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to PCBL.BO's ROE of +0.05%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to PCBL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check PCBL.BO's competition here
APCOTEXIND.NS vs JUBLINGREA.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, JUBLINGREA.BO has a market cap of 98.7B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while JUBLINGREA.BO trades at ₹621.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas JUBLINGREA.BO's P/E ratio is 35.70. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to JUBLINGREA.BO's ROE of +0.09%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to JUBLINGREA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check JUBLINGREA.BO's competition here
APCOTEXIND.NS vs JUBLINGREA.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, JUBLINGREA.NS has a market cap of 98.7B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while JUBLINGREA.NS trades at ₹619.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas JUBLINGREA.NS's P/E ratio is 35.67. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to JUBLINGREA.NS's ROE of +0.09%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to JUBLINGREA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check JUBLINGREA.NS's competition here
APCOTEXIND.NS vs AMIORG.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, AMIORG.NS has a market cap of 96.3B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while AMIORG.NS trades at ₹1,176.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas AMIORG.NS's P/E ratio is 119.06. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to AMIORG.NS's ROE of +0.12%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to AMIORG.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check AMIORG.NS's competition here
APCOTEXIND.NS vs AMIORG.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, AMIORG.BO has a market cap of 96.3B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while AMIORG.BO trades at ₹1,176.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas AMIORG.BO's P/E ratio is 118.95. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to AMIORG.BO's ROE of +0.12%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to AMIORG.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check AMIORG.BO's competition here
APCOTEXIND.NS vs ALKYLAMINE.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, ALKYLAMINE.BO has a market cap of 94.7B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while ALKYLAMINE.BO trades at ₹1,805.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas ALKYLAMINE.BO's P/E ratio is 52.59. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to ALKYLAMINE.BO's ROE of +0.12%. Regarding short-term risk, APCOTEXIND.NS is less volatile compared to ALKYLAMINE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check ALKYLAMINE.BO's competition here
APCOTEXIND.NS vs ALKYLAMINE.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, ALKYLAMINE.NS has a market cap of 94.7B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while ALKYLAMINE.NS trades at ₹1,796.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas ALKYLAMINE.NS's P/E ratio is 52.67. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to ALKYLAMINE.NS's ROE of +0.12%. Regarding short-term risk, APCOTEXIND.NS is less volatile compared to ALKYLAMINE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check ALKYLAMINE.NS's competition here
APCOTEXIND.NS vs CLEAN.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, CLEAN.BO has a market cap of 81.6B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while CLEAN.BO trades at ₹747.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas CLEAN.BO's P/E ratio is 35.53. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to CLEAN.BO's ROE of +0.16%. Regarding short-term risk, APCOTEXIND.NS is less volatile compared to CLEAN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check CLEAN.BO's competition here
APCOTEXIND.NS vs CLEAN.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, CLEAN.NS has a market cap of 81.6B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while CLEAN.NS trades at ₹752.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas CLEAN.NS's P/E ratio is 35.50. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to CLEAN.NS's ROE of +0.16%. Regarding short-term risk, APCOTEXIND.NS is less volatile compared to CLEAN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check CLEAN.NS's competition here
APCOTEXIND.NS vs BALAMINES.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, BALAMINES.NS has a market cap of 72.6B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while BALAMINES.NS trades at ₹2,131.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas BALAMINES.NS's P/E ratio is 43.41. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to BALAMINES.NS's ROE of +0.09%. Regarding short-term risk, APCOTEXIND.NS is less volatile compared to BALAMINES.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check BALAMINES.NS's competition here
APCOTEXIND.NS vs BALAMINES.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, BALAMINES.BO has a market cap of 72.6B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while BALAMINES.BO trades at ₹2,130.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas BALAMINES.BO's P/E ratio is 43.52. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to BALAMINES.BO's ROE of +0.09%. Regarding short-term risk, APCOTEXIND.NS is less volatile compared to BALAMINES.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check BALAMINES.BO's competition here
APCOTEXIND.NS vs KINGFA.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, KINGFA.BO has a market cap of 70.7B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while KINGFA.BO trades at ₹5,050.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas KINGFA.BO's P/E ratio is 36.26. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to KINGFA.BO's ROE of +0.18%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to KINGFA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check KINGFA.BO's competition here
APCOTEXIND.NS vs KINGFA.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, KINGFA.NS has a market cap of 70.4B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while KINGFA.NS trades at ₹5,060.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas KINGFA.NS's P/E ratio is 36.12. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to KINGFA.NS's ROE of +0.18%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to KINGFA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check KINGFA.NS's competition here
APCOTEXIND.NS vs SUDARSCHEM.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, SUDARSCHEM.NS has a market cap of 70.2B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while SUDARSCHEM.NS trades at ₹854.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas SUDARSCHEM.NS's P/E ratio is 314.52. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to SUDARSCHEM.NS's ROE of +0.01%. Regarding short-term risk, APCOTEXIND.NS is less volatile compared to SUDARSCHEM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check SUDARSCHEM.NS's competition here
APCOTEXIND.NS vs SUDARSCHEM.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, SUDARSCHEM.BO has a market cap of 70.2B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while SUDARSCHEM.BO trades at ₹854.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas SUDARSCHEM.BO's P/E ratio is 132.07. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to SUDARSCHEM.BO's ROE of +0.01%. Regarding short-term risk, APCOTEXIND.NS is less volatile compared to SUDARSCHEM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check SUDARSCHEM.BO's competition here
APCOTEXIND.NS vs GALAXYSURF.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, GALAXYSURF.BO has a market cap of 61.3B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while GALAXYSURF.BO trades at ₹1,688.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas GALAXYSURF.BO's P/E ratio is 22.97. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to GALAXYSURF.BO's ROE of +0.11%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to GALAXYSURF.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check GALAXYSURF.BO's competition here
APCOTEXIND.NS vs GALAXYSURF.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, GALAXYSURF.NS has a market cap of 61.3B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while GALAXYSURF.NS trades at ₹1,696.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas GALAXYSURF.NS's P/E ratio is 22.94. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to GALAXYSURF.NS's ROE of +0.11%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to GALAXYSURF.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check GALAXYSURF.NS's competition here
APCOTEXIND.NS vs NEOGEN.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, NEOGEN.NS has a market cap of 51.1B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while NEOGEN.NS trades at ₹1,995.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas NEOGEN.NS's P/E ratio is 178.69. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to NEOGEN.NS's ROE of +0.04%. Regarding short-term risk, APCOTEXIND.NS is less volatile compared to NEOGEN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check NEOGEN.NS's competition here
APCOTEXIND.NS vs NEOGEN.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, NEOGEN.BO has a market cap of 51.1B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while NEOGEN.BO trades at ₹1,979.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas NEOGEN.BO's P/E ratio is 178.14. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to NEOGEN.BO's ROE of +0.04%. Regarding short-term risk, APCOTEXIND.NS is less volatile compared to NEOGEN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check NEOGEN.BO's competition here
APCOTEXIND.NS vs INDIGOPNTS.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, INDIGOPNTS.BO has a market cap of 46.5B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while INDIGOPNTS.BO trades at ₹977.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas INDIGOPNTS.BO's P/E ratio is 32.17. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to INDIGOPNTS.BO's ROE of +0.14%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to INDIGOPNTS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check INDIGOPNTS.BO's competition here
APCOTEXIND.NS vs INDIGOPNTS.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, INDIGOPNTS.NS has a market cap of 46.4B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while INDIGOPNTS.NS trades at ₹976.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas INDIGOPNTS.NS's P/E ratio is 32.11. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to INDIGOPNTS.NS's ROE of +0.14%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to INDIGOPNTS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check INDIGOPNTS.NS's competition here
APCOTEXIND.NS vs RESPONIND.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, RESPONIND.BO has a market cap of 45.9B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while RESPONIND.BO trades at ₹164.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas RESPONIND.BO's P/E ratio is 30.92. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to RESPONIND.BO's ROE of +0.10%. Regarding short-term risk, APCOTEXIND.NS is less volatile compared to RESPONIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check RESPONIND.BO's competition here
APCOTEXIND.NS vs RESPONIND.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, RESPONIND.NS has a market cap of 45.7B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while RESPONIND.NS trades at ₹164.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas RESPONIND.NS's P/E ratio is 30.77. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to RESPONIND.NS's ROE of +0.10%. Regarding short-term risk, APCOTEXIND.NS is less volatile compared to RESPONIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check RESPONIND.NS's competition here
APCOTEXIND.NS vs GULFOILLUB.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, GULFOILLUB.BO has a market cap of 45.3B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while GULFOILLUB.BO trades at ₹916.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas GULFOILLUB.BO's P/E ratio is 12.51. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to GULFOILLUB.BO's ROE of +0.23%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to GULFOILLUB.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check GULFOILLUB.BO's competition here
APCOTEXIND.NS vs GULFOILLUB.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, GULFOILLUB.NS has a market cap of 45.3B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while GULFOILLUB.NS trades at ₹917.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas GULFOILLUB.NS's P/E ratio is 12.50. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to GULFOILLUB.NS's ROE of +0.23%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to GULFOILLUB.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check GULFOILLUB.NS's competition here
APCOTEXIND.NS vs LXCHEM.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, LXCHEM.NS has a market cap of 43.1B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while LXCHEM.NS trades at ₹149.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas LXCHEM.NS's P/E ratio is 54.38. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to LXCHEM.NS's ROE of +0.04%. Regarding short-term risk, APCOTEXIND.NS is less volatile compared to LXCHEM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check LXCHEM.NS's competition here
APCOTEXIND.NS vs LXCHEM.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, LXCHEM.BO has a market cap of 43.1B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while LXCHEM.BO trades at ₹150.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas LXCHEM.BO's P/E ratio is 54.56. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to LXCHEM.BO's ROE of +0.04%. Regarding short-term risk, APCOTEXIND.NS is less volatile compared to LXCHEM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check LXCHEM.BO's competition here
APCOTEXIND.NS vs ADVENZYMES.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, ADVENZYMES.NS has a market cap of 41.7B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while ADVENZYMES.NS trades at ₹371.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas ADVENZYMES.NS's P/E ratio is 24.69. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to ADVENZYMES.NS's ROE of +0.11%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to ADVENZYMES.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check ADVENZYMES.NS's competition here
APCOTEXIND.NS vs ADVENZYMES.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, ADVENZYMES.BO has a market cap of 41.7B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while ADVENZYMES.BO trades at ₹367.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas ADVENZYMES.BO's P/E ratio is 24.69. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to ADVENZYMES.BO's ROE of +0.11%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to ADVENZYMES.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check ADVENZYMES.BO's competition here
APCOTEXIND.NS vs VISHNU.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, VISHNU.NS has a market cap of 40B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while VISHNU.NS trades at ₹580.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas VISHNU.NS's P/E ratio is 28.13. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to VISHNU.NS's ROE of +0.15%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to VISHNU.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check VISHNU.NS's competition here
APCOTEXIND.NS vs VISHNU.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, VISHNU.BO has a market cap of 40B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while VISHNU.BO trades at ₹582.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas VISHNU.BO's P/E ratio is 28.15. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to VISHNU.BO's ROE of +0.15%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to VISHNU.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check VISHNU.BO's competition here
APCOTEXIND.NS vs SOTL.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, SOTL.BO has a market cap of 39B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while SOTL.BO trades at ₹550.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas SOTL.BO's P/E ratio is 21.43. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to SOTL.BO's ROE of +0.11%. Regarding short-term risk, APCOTEXIND.NS is less volatile compared to SOTL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check SOTL.BO's competition here
APCOTEXIND.NS vs SOTL.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, SOTL.NS has a market cap of 38.9B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while SOTL.NS trades at ₹550.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas SOTL.NS's P/E ratio is 21.43. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to SOTL.NS's ROE of +0.11%. Regarding short-term risk, APCOTEXIND.NS is less volatile compared to SOTL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check SOTL.NS's competition here
APCOTEXIND.NS vs PREMEXPLN.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, PREMEXPLN.BO has a market cap of 38.9B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while PREMEXPLN.BO trades at ₹685.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas PREMEXPLN.BO's P/E ratio is 85.09. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to PREMEXPLN.BO's ROE of +0.17%. Regarding short-term risk, APCOTEXIND.NS is less volatile compared to PREMEXPLN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check PREMEXPLN.BO's competition here
APCOTEXIND.NS vs PREMEXPLN.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, PREMEXPLN.NS has a market cap of 38.8B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while PREMEXPLN.NS trades at ₹685.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas PREMEXPLN.NS's P/E ratio is 84.94. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to PREMEXPLN.NS's ROE of +0.17%. Regarding short-term risk, APCOTEXIND.NS is less volatile compared to PREMEXPLN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check PREMEXPLN.NS's competition here
APCOTEXIND.NS vs TANFACIND.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, TANFACIND.BO has a market cap of 38.3B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while TANFACIND.BO trades at ₹1,847.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas TANFACIND.BO's P/E ratio is 54.43. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to TANFACIND.BO's ROE of +0.22%. Regarding short-term risk, APCOTEXIND.NS is less volatile compared to TANFACIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check TANFACIND.BO's competition here
APCOTEXIND.NS vs POCL.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, POCL.BO has a market cap of 37.8B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while POCL.BO trades at ₹1,212.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas POCL.BO's P/E ratio is 28.05. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to POCL.BO's ROE of +0.20%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to POCL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check POCL.BO's competition here
APCOTEXIND.NS vs POCL.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, POCL.NS has a market cap of 37.7B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while POCL.NS trades at ₹1,215.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas POCL.NS's P/E ratio is 28.05. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to POCL.NS's ROE of +0.20%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to POCL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check POCL.NS's competition here
APCOTEXIND.NS vs GRAUWEIL.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, GRAUWEIL.NS has a market cap of 33.7B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while GRAUWEIL.NS trades at ₹71.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas GRAUWEIL.NS's P/E ratio is 20.56. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to GRAUWEIL.NS's ROE of +0.17%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to GRAUWEIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check GRAUWEIL.NS's competition here
APCOTEXIND.NS vs GRAUWEIL.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, GRAUWEIL.BO has a market cap of 33.7B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while GRAUWEIL.BO trades at ₹71.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas GRAUWEIL.BO's P/E ratio is 20.55. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to GRAUWEIL.BO's ROE of +0.17%. Regarding short-term risk, APCOTEXIND.NS is less volatile compared to GRAUWEIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check GRAUWEIL.BO's competition here
APCOTEXIND.NS vs YASHO.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, YASHO.BO has a market cap of 30.7B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while YASHO.BO trades at ₹2,457.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas YASHO.BO's P/E ratio is 121.71. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to YASHO.BO's ROE of +0.06%. Regarding short-term risk, APCOTEXIND.NS is less volatile compared to YASHO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check YASHO.BO's competition here
APCOTEXIND.NS vs YASHO.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, YASHO.NS has a market cap of 30.7B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while YASHO.NS trades at ₹2,475.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas YASHO.NS's P/E ratio is 121.12. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to YASHO.NS's ROE of +0.06%. Regarding short-term risk, APCOTEXIND.NS is less volatile compared to YASHO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check YASHO.NS's competition here
APCOTEXIND.NS vs JINDALPOLY.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, JINDALPOLY.NS has a market cap of 29.3B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while JINDALPOLY.NS trades at ₹700.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas JINDALPOLY.NS's P/E ratio is -13.82. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to JINDALPOLY.NS's ROE of -0.06%. Regarding short-term risk, APCOTEXIND.NS is less volatile compared to JINDALPOLY.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check JINDALPOLY.NS's competition here
APCOTEXIND.NS vs JINDALPOLY.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, JINDALPOLY.BO has a market cap of 29.3B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while JINDALPOLY.BO trades at ₹702.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas JINDALPOLY.BO's P/E ratio is -22.60. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to JINDALPOLY.BO's ROE of -0.06%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to JINDALPOLY.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check JINDALPOLY.BO's competition here
APCOTEXIND.NS vs ROSSARI.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, ROSSARI.BO has a market cap of 28.6B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while ROSSARI.BO trades at ₹511.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas ROSSARI.BO's P/E ratio is 19.16. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to ROSSARI.BO's ROE of +0.12%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to ROSSARI.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check ROSSARI.BO's competition here
APCOTEXIND.NS vs ROSSARI.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, ROSSARI.NS has a market cap of 28.6B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while ROSSARI.NS trades at ₹510.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas ROSSARI.NS's P/E ratio is 19.15. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to ROSSARI.NS's ROE of +0.12%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to ROSSARI.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check ROSSARI.NS's competition here
APCOTEXIND.NS vs POLYPLEX.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, POLYPLEX.NS has a market cap of 28.2B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while POLYPLEX.NS trades at ₹889.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas POLYPLEX.NS's P/E ratio is 62.75. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to POLYPLEX.NS's ROE of +0.01%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to POLYPLEX.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check POLYPLEX.NS's competition here
APCOTEXIND.NS vs POLYPLEX.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, POLYPLEX.BO has a market cap of 28.2B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while POLYPLEX.BO trades at ₹888.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas POLYPLEX.BO's P/E ratio is 62.87. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to POLYPLEX.BO's ROE of +0.01%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to POLYPLEX.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check POLYPLEX.BO's competition here
APCOTEXIND.NS vs APCOTEXIND.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, APCOTEXIND.BO has a market cap of 28B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while APCOTEXIND.BO trades at ₹536.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas APCOTEXIND.BO's P/E ratio is 33.52. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to APCOTEXIND.BO's ROE of +0.18%. Regarding short-term risk, APCOTEXIND.NS is less volatile compared to APCOTEXIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check APCOTEXIND.BO's competition here
APCOTEXIND.NS vs XPROINDIA.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, XPROINDIA.NS has a market cap of 27.9B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while XPROINDIA.NS trades at ₹1,166.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas XPROINDIA.NS's P/E ratio is 141.01. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to XPROINDIA.NS's ROE of +0.03%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to XPROINDIA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check XPROINDIA.NS's competition here
APCOTEXIND.NS vs XPROINDIA.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, XPROINDIA.BO has a market cap of 27.8B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while XPROINDIA.BO trades at ₹1,165.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas XPROINDIA.BO's P/E ratio is 140.57. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to XPROINDIA.BO's ROE of +0.03%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to XPROINDIA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check XPROINDIA.BO's competition here
APCOTEXIND.NS vs JUBLCPL.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, JUBLCPL.NS has a market cap of 27.5B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while JUBLCPL.NS trades at ₹1,823.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas JUBLCPL.NS's P/E ratio is 21.73. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to JUBLCPL.NS's ROE of +0.32%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to JUBLCPL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check JUBLCPL.NS's competition here
APCOTEXIND.NS vs TATVA.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, TATVA.BO has a market cap of 27.1B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while TATVA.BO trades at ₹1,115.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas TATVA.BO's P/E ratio is 64.45. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to TATVA.BO's ROE of +0.06%. Regarding short-term risk, APCOTEXIND.NS is less volatile compared to TATVA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check TATVA.BO's competition here
APCOTEXIND.NS vs TATVA.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, TATVA.NS has a market cap of 27.1B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while TATVA.NS trades at ₹1,113.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas TATVA.NS's P/E ratio is 64.48. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to TATVA.NS's ROE of +0.06%. Regarding short-term risk, APCOTEXIND.NS is less volatile compared to TATVA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check TATVA.NS's competition here
APCOTEXIND.NS vs JUBLCPL.BO Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, JUBLCPL.BO has a market cap of 27.1B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while JUBLCPL.BO trades at ₹1,812.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas JUBLCPL.BO's P/E ratio is 21.44. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to JUBLCPL.BO's ROE of +0.13%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to JUBLCPL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check JUBLCPL.BO's competition here
APCOTEXIND.NS vs KIRIINDUS.NS Comparison June 2026
APCOTEXIND.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APCOTEXIND.NS stands at 27.9B. In comparison, KIRIINDUS.NS has a market cap of 26.5B. Regarding current trading prices, APCOTEXIND.NS is priced at ₹534.85, while KIRIINDUS.NS trades at ₹396.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APCOTEXIND.NS currently has a P/E ratio of 27.56, whereas KIRIINDUS.NS's P/E ratio is 0.45. In terms of profitability, APCOTEXIND.NS's ROE is +0.18%, compared to KIRIINDUS.NS's ROE of +1.37%. Regarding short-term risk, APCOTEXIND.NS is more volatile compared to KIRIINDUS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.NS.Check KIRIINDUS.NS's competition here